Hello Tomorrow Selects Phyteau As One Of The Top 500 Deeptech Startups Worldwide.
We are pleased to announce that Phyteau has been selected as one of Hello Tomorrow’s Top 500 deeptech startups worldwide in Global Health for 2019! The Hello Tomorrow Global Challenge is a worldwide renowned science & technology startup competition designed specifically to address the needs of deeptech entrepreneurs across several different industries and technologies. It gives a platform to innovators using technology to solve the world’s toughest challenges. We were selected by Hello Tomorrow from over 4,500 applications from 119 countries and recognizes us as one of the world’s most promising projects in deep tech.
We are looking forward to engaging with technology innovators and thought leaders from around the world at the Hello Tomorrow Global Summit in Paris on 13-15th March 2019, www.hello-tomorrow.org/summit. See you there.
Phyteau is developing safe and effective therapeutics for diabetes, obesity prediabetes and related metabolic conditions. Our therapeutics work entirely in the gut where they activate specialized metabolic cells causing the release of therapeutic levels of key metabolic hormones. The body’s own hormones work naturally and safely to control blood sugar, metabolism, appetite and food intake. Our range of completely safe and side-effect free agents and ingredients allows us to bring our technologies to multiple markets worldwide – including nutraceuticals, targeted diabetic, diet, medical and functional foods, and pharmaceuticals. For more information, visit www.phyteau.co